|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00383 TIANAN MEDICARE
Nominal 
0.950 0.000 (0.000%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -0.757% | 0.813% | 0.434% | -3.677% | -3.971% |
| ROAE (%) | -1.493% | 1.587% | 0.873% | -7.592% | -7.878% |
| Return on Capital Employed (%) | -1.134% | 1.212% | 0.614% | -5.879% | -6.383% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 18.896% | 20.663% | 18.506% | 18.469% | 18.275% |
| EBITDA Margin (%) | 5.712% | 9.275% | 10.005% | 2.961% | 3.477% |
| Pre-tax Profit Margin (%) | -0.029% | 3.503% | 2.601% | -8.149% | -7.548% |
| Net Profit Margin (%) | -1.637% | 1.768% | 0.936% | -8.594% | -9.381% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 1.096 X | 1.166 X | 1.189 X | 0.914 X | 0.734 X |
| Quick Ratio (X) | 1.058 X | 1.127 X | 1.146 X | 0.883 X | 0.714 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 47.619% | 46.457% | 47.073% | 51.157% | 50.788% |
| Total Debt / Total Assets (%) | 25.150% | 23.629% | 22.584% | 30.286% | 27.853% |
| Net Debt / Total Assets (%) | 4.212% | -1.391% | -2.591% | 12.064% | 11.333% |
| Total Debt / Shareholders' Funds (%) | 50.327% | 45.971% | 44.166% | 62.962% | 57.154% |
| Long Term Debt / Shareholders' Funds (%) | 24.483% | 24.401% | 26.693% | 27.540% | 21.501% |
| Net Debt / Shareholders' Funds (%) | 8.428% | -2.706% | -5.068% | 25.079% | 23.255% |
| Net Cash / (Debt) ($) | (149.456M) | 49.220M | 91.634M | (389.971M) | (395.466M) |
| Net Cash / (Debt) per share ($) | (0.138) | 0.045 | 0.084 | (0.533) | (0.540) |
| Total Debt / Capital Employed (%) | 37.740% | 35.236% | 33.396% | 46.580% | 45.185% |
| Interest Coverage Ratio (X) | 0.979 X | 2.958 X | 1.854 X | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 12.508 Day | 13.257 Day | 12.000 Day | 9.650 Day | 7.296 Day |
| Receivables Turnover (Day) | 34.572 Day | 25.490 Day | 18.103 Day | 27.992 Day | 34.409 Day |
| Payables Turnover (Day) | 35.959 Day | 46.092 Day | 45.079 Day | 49.561 Day | 47.277 Day |
| Remarks: | Real time quote last updated: 18/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -26,816 |
| %Change | -- |
| EPS / (LPS) | HKD -0.025 |
| NBV Per Share ($) | HKD 1.641 |